WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Monday, July 13, 2020 
Add Press Release News | News Feeds Feeds | Email This News Email


Sage Growth Partners Publishes New Survey Findings on Healthcare Venture Capital
Tuesday, November 19, 2019

Investors and CEOs differ on the number one value investors bring to the table; agree that selecting a proven team on both sides is paramount

BALTIMORE, Nov. 11, 2019 /PRNewswire/ -- The U.S. healthcare market saw a 14.4 percent increase in mergers and acquisitions from 2017-2018, fueled by soaring domestic venture capital investment - an all-time high of $130.9 billion invested in U.S.-based startups in 2018 alone. Compounding the pace and complexity of deal flow are sweeping industry trends ranging from managing and measuring health outcomes to reducing the overall cost of care.

Given this ripe environment, Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, conducted a market survey to gauge the relative priorities and attitudes of investors and CEOs of U.S.-based healthcare companies.

Access the full report here. Key findings include:

Investors want to help CEOs run the business - but CEOs value this less than other benefits

    --  When investors were asked to identify the top three benefits they
        furnish a portfolio company, providing board leadership (No. 1) and
        recruiting senior management (No. 4) were among the highest ranked
        responses.
    --  When CEOs were asked the top three factors they seek in a partner, the
        benefits cited by investors - board leadership (No. 7) and recruiting
        senior management (No. 9) came in at the bottom.
    --  Instead, CEOs cited credibility to the market (No. 1) and expertise
        related to the market (No. 4) among their highest ranked responses -
        whereas investors ranked credibility to the market as No. 8 and
        expertise related to the market as No. 6.
    --  Investors and CEOs are aligned on the value investors provide in making
        connections to customers and subject matter experts (No. 2 for both) and
        acceleration (No. 3 for both).

Investors are looking to mitigate risk

    --  When asked about markets that are most conducive to business growth, 63
        percent said they would rather invest in a top 10 company in a
        fragmented market over a top three company in a consolidated market.
    --  This risk mitigation was also reflected by the 83 percent of investors
        who would prefer threats posed by competing businesses versus those
        resulting from regulation (17 percent).

People come first: investors and CEOs both value proven teams with a track record of success

    --  By a 2:1 margin, investors indicated their preference for a company with
        a proven team and an average product (67 percent) over a company with a
        differentiated product and an average team (33 percent).
    --  In a separate question, investors unanimously preferred a differentiated
        product in a $1 billion market over an average product in a $5 billion
        market.
    --  Meanwhile, more than half (60 percent) of CEOs indicated that an
        excellent track record of success is more important in their choice of a
        financial firm than the terms of a given deal.
    --  Eighty percent of CEOs indicated that being a first-tier investment with
        a firm that is respected is more important than being a second-tier
        investment with a firm that is renowned.

"Business opportunities in healthcare today are driven by two key factors - the industry's widespread waste and inefficiencies, and public and private sector mandates to reduce costs while increasing health outcomes," said Dan D'Orazio, SGP's CEO. "As a result, there is an abundance of potential partners and investment capital. It's not surprising that investors and CEOs don't completely see eye to eye on the perceived benefits of venture capital investment. However, they will have to find a way to successfully overlap their needs to benefit from the most valuable resource in their arsenal - the people."

Methodology
Sage Growth Partners engaged 30 investors who have provided capital to healthcare companies at stages ranging from seed to buy-out; each had made at least one, and upwards of five, investments in the last 12 months. Also surveyed were 30 CEOs of healthcare companies, of whom half received funding in the past 12 months; the last round of funding received by the group of CEOs spanned from $250,000 to $100 million. At the conclusion of the survey, SGP made a donation to the Johns Hopkins Children's Center on behalf of respondents.

About Sage Growth Partners

Sage Growth Partners accelerates commercial success for B2B, B2B2C, and B2C healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing.

Founded in 2005, Sage Growth Partners is located in Baltimore, MD and serves clients such as Philips Healthcare, Quest Diagnostics, Hughes and Company, Olive, It's Never 2 Late, and Noro-Moseley Partners. Visit us online at www.sage-growth.com.

Media Contact
Vanessa Ulrich
(410) 534.1161
vulrich@sage-growth.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/sage-growth-partners-publishes-new-survey-findings-on-healthcare-venture-capital-300955012.html

SOURCE Sage Growth Partners



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav $525.4 Billion Worldwide IoT Chip Industry to 2025 - Featuring Nordic Semiconductor, Gainspan & Expressif Systems Among Others | Jul 13, 2020
Nav Regeneron Utilizes Icertis Contract Management Platform for Contracting System Transformation | Jul 13, 2020
Nav VOXX International Corporation Acquires Majority Of Directed's Automotive Aftermarket Business | Jul 13, 2020
Nav Peptide Therapeutics: Contract API Manufacturing Market Outlook, 2030 | Jul 13, 2020
Nav Global Prosthetic Joint Infection (PJI) Market Assessment 2017-2030: Pipeline, Epidemiology, Drugs, Reimbursement Scenario, Competitive Intelligence | Jul 13, 2020
Nav Introducing Editor X, Advanced Website Creation Platform Raising the Standard of Web Design | Jul 13, 2020
Nav Global Test & Measurement Market Outlook 2020-2025 - Trends & Growth Opportunities for Autonomous Cars and Electric Vehicles | Jul 13, 2020
Nav Qualfon Recognized as a Major Contender in the Everest Group PEAK Matrix Assessment | Jul 13, 2020
Nav ALK Non-Small Cell Lung Cancer Markets, Forecast to 2030 - Market Analysis, Pipeline, Epidemiology, Drug Sales & Shares by Country and Competition | Jul 13, 2020
Nav Assessment of Frontotemporal Dementia Markets in United States, Germany, Spain, Italy, France, United Kingdom and Japan (2017-2030) | Jul 13, 2020
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News